scAAV-FIX gene therapy vector

self-complementary adeno-associated viral vector expressing coagulation factor IX · St. Jude Children's Research Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for scAAV-FIX gene therapy vector, covering 2026-04-02 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector For Gene Transfer in Hemophilia B [Phase 1]

See pricing